Hematopoietic tumors and metastases involving bone

Radiologic Clinics of North America

Volumn 49, Issue 6, 2011, Pages 1163-1183

  Kim, Sung H ^a   Smith, Stacy E ^b   Mulligan, Michael E ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Langerhans cell histiocytosis; Leukemia; Lymphoma; Metastases; Myeloma

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HISTIOCYTOSIS X; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; JAW OSTEONECROSIS; LEUKEMIA; LYMPHOMA; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGIC FRACTURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

BONE NEOPLASMS; FLUORODEOXYGLUCOSE F18; HEMATOLOGIC NEOPLASMS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LEUKEMIA; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MULTIPLE MYELOMA; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 82455188370     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2011.07.004     Document Type: Review

References (56)

1. Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002, 2:584-593.
2. Coleman R.E. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006, 12:6243s-6249s.
3. Batson O.V. The function of the vertebral veins and their role in the spread of metastases. Ann Surg 1940, 112:138-149.
4. Kitazawa S., Maeda S. Development of skeletal metastases. Clin Orthop Relat Res 1995, 312:45-50.
5. Simon M.A., Bartucci E.J. The search for the primary tumor in patients with skeletal metastases of unknown origin. Cancer 1986, 58:1088-1095.
6. Sherry M.M., Greco F.A., Johnson D.H., et al. Metastatic breast cancer confined to the skeletal system. An indolent disease. Am J Med 1986, 81:381-386.
7. Disler D.G., McCauley T.R., Ratner L.M., et al. In-phase and out-of-phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water. Am J Roentgenol 1997, 169:1439-1447.
8. Tumeh S.S., Beadle G., Kaplan W.D. Clinical significance of solitary rib lesions in patients with extraskeletal malignancy. J Nucl Med 1985, 26:1140-1143.
9. Corcoran R.J., Thrall J.H., Kyle R.W., et al. Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 1976, 121:663-667.
10. Taira A.V., Herfkens R.J., Gambhir S.S., et al. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology 2007, 243:204-211.
11. Reske S., Blumstein N., Neumaier B., et al. Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med 2006, 47:1249-1254.
12. Bredella M.A., Steinbach L., Caputo G., et al. Value of FDG PET in the assessment of patients with multiple myeloma. Am J Roentgenol 2005, 184:1199-1204.
13. Edelstyn G.A., Gillespie P.J., Grebbell F.S. The radiological demonstration of osseous metastases: experimental observations. Clin Radiol 1967, 18:158-162.
14. Chen W.T., Shih T.T., Chen R.C., et al. Blood perfusion of vertebral lesions evaluated with gadolinium-enhanced dynamic MRI: in comparison with compression fracture and metastasis. J Magn Reson Imaging 2002, 15:308-314.
15. Sartoris D.J., Clopton P., Nemcek A., et al. Vertebral-body collapse in focal and diffuse disease: patterns of pathologic processes. Radiology 1986, 160:479-483.
16. Algra P.R., Heimans J.J., Valk J., et al. Do metastases in vertebrae begin in the body or the pedicles? Imaging study in 45 patients. Am J Roentgenol 1992, 158:1275-1279.
17. Cuénod C.A., Laredo J.D., Chevret S., et al. Acute vertebral collapse due to osteoporosis or malignancy: appearance on unenhanced and gadolinium-enhanced MR images. Radiology 1996, 199:541-549.
18. Baur A., Stäbler A., Brüning R., et al. Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures. Radiology 1998, 207:349-356.
19. Dennis J.M. The solitary dense vertebral body. Radiology 1961, 77:618-621.
20. Coury C. Hippocration fingers and hypertrophic osteoarthropathy. A study of 350 cases. Br J Dis Chest 1960, 54:202-209.
21. Deutsch A., Resnick D., Niwayama G. Case report 145. Bilateral, almost symmetrical skeletal metastases (both femora) from bronchogenic carcinoma. Skeletal Radiol 1981, 6:144-148.
22. Tubiana-Hulin M. Incidence, prevalence and distribution of bone metastases. Bone 1991, 12:S9-S10.
23. Saad F., Lipton A., Cook R., et al. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 2007, 110:1860-1867.
24. Van der Linden Y.M., Dijkstra P.D., Kroon H.M., et al. Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br 2004, 86:566-573.
25. Beals R.K., Lawton G.D., Snell W.E. Prophylactic internal fixation of the femur in metastatic breast cancer. Cancer 1971, 28:1350-1354.
26. Mirels H. Metastatic disease in long bones. Clin Orthop Relat Res 1989, 249:256-264.
27. Harrington K.D. The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg Am 1981, 63:653-664.
28. Durie B.G., Kyle R.A., Belch A., et al. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J 2003, 4:379-398.
29. Durie B.G., Salmon S.E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975, 36:842-854.
30. Dimopoulos M., Terpos E., Comenzo R.L., et al. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia 2009, 23:1545-1556.
31. Tian E., Zhan F., Walker R., et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003, 349:2483-2494.
32. Mulligan M. Myeloma update. Semin Musculoskelet Radiol 2007, 11:231-239.
33. Dispenzieri A. POEMS syndrome. Hematology Am Soc Hematol Educ Program 2005, 360-367.
34. Baur A., Stäbler A., Nagel D., et al. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?. Cancer 2002, 95:1334-1345.
35. Van de Berg B.C., Lecouvet F.E., Michaux L., et al. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis. Radiology 1996, 201:243-246.
36. Dimopoulos M.A., Moulopoulos A., Smith T., et al. Risk of disease progression in asymptomatic multiple myeloma. Am J Med 1993, 94:57-61.
37. Hartman R.P., Sundaram M., Okuno S.H., et al. Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies: incidence and MRI findings. Am J Roentgenol 2004, 183:645-653.
38. Fechtner K., Hillengass J., Delorme S., et al. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems. Radiology 2010, 257:195-204.
39. Breyer R.J., Mulligan M.E., Smith S.E., et al. Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma. Skeletal Radiol 2006, 35:632-640.
40. Kusumoto S., Jinnai I., Itoh K., et al. Magnetic resonance imaging patterns in patients with multiple myeloma. Br J Haematol 1997, 99:649-655.
41. Walker R., Barlogie B., Haessler J., et al. Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol 2007, 25:1121-1128.
42. Barlogie B., Anaissie E., van Rhee F., et al. The Arkansas approach to therapy of patients with multiple myeloma. Best Pract Res Clin Haematol 2007, 20:761-781.
43. Badros A., Terpos E., Katodritou E., et al. Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Clin Oncol 2008, 26:5904-5909.
44. Park-Wyllie L.Y., Mamdani M.M., Juurlink D.N., et al. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 2011, 305:783-789.
45. Mulligan M., Chirindel A., Karchevsky M. Characterizing and predicting pathologic spine fractures in myeloma patients with FDG PET/CT and MR imaging. Cancer Invest 2011, 29(5):370-376.
46. Moulopoulos L.A., Dimopoulos M.A., Alexanian R., et al. Multiple myeloma: MR patterns of response to treatment. Radiology 1994, 193:441-446.
47. Fenchel M., Konaktchieva M., Weisel K., et al. Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results. Eur Radiol 2010, 20:899-906.
48. Lin C., Luciani A., Belhadj K., et al. Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging. Radiology 2010, 254:521-531.
49. Horger M., Weisel K., Horger W., et al. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results. Am J Roentgenol 2011, 196:1373.
50. Mulligan M.E., McRae G.A., Murphey M.D. Imaging features of primary lymphoma of bone. Am J Roentgenol 1999, 173:1691-1697.
51. Kirsch J., Ilaslan H., Bauer T.W., et al. The incidence of imaging findings, and the distribution of skeletal lymphoma in a consecutive patient population seen over 5 years. Skeletal Radiol 2006, 35:590-594.
52. Lecouvet F.E., Vande Berg B.C., Michaux L., et al. Early chronic lymphocytic leukemia: prognostic value of quantitative bone marrow MR imaging findings and correlation with hematologic variables. Radiology 1997, 204:813-818.
53. Chen B.B., Hsu C.Y., Yu C.W., et al. Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission. Radiology 2011, 258:821-831.
54. Azouz E.M., Saigal G., Rodriquez M., et al. Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol 2005, 35:103-115.
55. Stull M.A., Kransdorf M.J., Devaney K.O. Langerhans cell histiocytosis of bone. Radiographics 1992, 12:801-823.
56. Rimondi E., Mavrogenis A., Rossi G., et al. CT-guided corticosteroid injection for solitary eosinophilic granuloma of the spine. Skeletal Radiol 2011, 40:757-764.